Metabolic syndrome prevalence in a multicultural population in Auckland, New Zealand

New Zealand Medical Journal

Volumn 120, Issue 1248, 2007, Pages

  Gentles, Dudley G R ^a   Metcalf, Patricia ^a   Dyall, Lorna C ^a   Sundborn, Gerhard ^a   Schaaf, David ^a   Black, Peter N ^a   Scragg, Robert K ^a   Jackson, Rodney T ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLUSTER ANALYSIS; CONFIDENCE INTERVAL; DIABETES MELLITUS; ETHNIC DIFFERENCE; EUROPE; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MAORI; METABOLIC SYNDROME X; NEW ZEALAND; OBESITY; PACIFIC ISLANDER; POPULATION RESEARCH; PREVALENCE; QUESTIONNAIRE; RISK FACTOR; CROSS-SECTIONAL STUDY; ETHNIC GROUP; ETHNOLOGY; MIDDLE AGED; STATISTICS;

ADULT; AGED; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NEW ZEALAND; OBESITY; PREVALENCE;

EID: 33846809473     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
2. National Cholesterol Education Program Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-421.
3. Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framingham risk score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med. 2005;165:2644-50.
4. Lorenzo C, Okoloise M, Williams K, et al. The metabolic syndrome as predictor of type 2 diabetes: The San Antonio Heart Study. Diabetes Care. 2003;26:3153-9.
5. Wilson PWF, D'Agostino RB, Parise H, et al. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112:3066-72.
6. Ninomiya JK, L'Italien G, Criqui MH, et al. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation. 2004;109:42-6.
7. Kurl S, Laukkanen JA, Niskanen L, et al. Metabolic syndrome and the risk of stroke in middle-aged men. Stroke. 2006;37:806-11.
8. McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care. 2005;28:385-90.
9. Najarian RMMD, Sullivan LMP, Kannel WBMD, et al. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: The Framingham Offspring Study. Arch Intern Med. 2006;166:106-11.
10. Laaksonen DE, Lakka H-M, Niskanen LK, et al. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol. 2002;156:1070-7.
11. Simmons D, Thompson CF. Prevalence of the metabolic syndrome among adult New Zealanders of Polynesian and European descent. Diabetes Care. 2004;27:3002-4.
12. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin of North Am. 2004;33:351-75.
13. Meigs JB, Wilson PW, Nathan DM, et al. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes. 2003;52:2160-7.
14. Jackson RT, Beaglehole R, Stewart AW. Blood pressure levels and the treatment of hypertension in Auckland, 1982. N Z Med J. 1983;96:751-4.
15. Trye P, Jackson R, Stewart A, et al. Trends and determinants of blood pressure in Auckland, New Zealand 1982-94. N Z Med J. 1996;109:179-81.
16. Metcalf PA, Scott A, Hutchinson R. Dual frame estimation for a survey with a complex design. In: 55th Session of the International Statistical Institute 2005. Sydney, Australia; 2005.
17. Sundborn G, Metcalf P, Schaaf D, et al. Differences in health-related socioeconomic characteristics among Pacific populations living in Auckland, New Zealand. N Z Med J. 2006;119(1228). URL: http://www.nzma.org.nz/journal/119-1228/1823
18. Alberti KGMM, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med. 1998;15:539-53.
19. SAS Institute Inc. SAS for Windows v 9.1. Cary, North Carolina: SAS Institute Inc; 2002-2003.
20. Jackson R, Chambless LE, Yang K, et al. Differences between respondents and nonrespondents in a multicenter community-based study vary by gender and ethnicity. J Clin Epidemiol. 1996;49:1441-6.
21. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415-28.
22. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care. 2004;27:2444-9.
23. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-9.
24. Hunt KJ, Heiss G, Sholinsky PD, Province MA. Familial history of metabolic disorders and the Multiple Metabolic syndrome: The NHLBI family heart study. Genet Epidemiol. 2000;19:395-409.
25. Lee WY, Jung CH, Park JS, et al. Effects of smoking, alcohol, exercise, education, and family history on the metabolic syndrome as defined by the ATP III. Diabetes Res Clin Pract. 2005;67:70-7.
26. Park Y-W, Zhu S, Palaniappan L, et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163:427-36.
27. Rimm EB, Williams P, Fosher K, et al. Moderate alcohol intake and lower risk of coronary heart disease: meta-analysis of effects on lipids and haemostatic factors. BMJ. 1999;319:1523-8.
28. Rappaport J, Fonseca V. Case-based study: from prediabetes to complications-opportunities for prevention. PLoS Medicine. 2005;2:e40.